Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Buy
59
CMA Quote, Financials, Valuation and Earnings
Last price:
$87.42
Seasonality move
:
2.96%
Day range:
$86.90 - $87.93
52-week range:
$48.12 - $90.44
Dividend yield:
3.27%
P/E ratio:
16.64x
P/S ratio:
2.48x
P/B ratio:
1.58x
Volume:
1.1M
Avg. volume:
1.4M
1-year change:
40.55%
Market cap:
$11.1B
Revenue:
$4.8B
EPS (TTM):
$5.23
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | $2.9B | $3.6B | $5.1B | $4.8B | |
| Revenue Growth (YoY) | -20.07% | -2.39% | 23.59% | 41.78% | -5.91% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $85M | -- | $8M | -$42M | -$11M | |
| Operating Expenses | -$638M | -$1.5B | -$1.5B | -$1.2B | -$909M | |
| Operating Income | $638M | $1.5B | $1.5B | $1.2B | $909M | |
| Net Interest Expenses | $81M | $35M | $101M | $768M | $511M | |
| EBT. Incl. Unusual Items | $621M | $1.5B | $1.5B | $1.1B | $888M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $124M | $322M | $325M | $263M | $190M | |
| Net Income to Company | $497M | $1.2B | $1.2B | $881M | $698M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $495M | $1.2B | $1.1B | $877M | $694M | |
| Basic EPS (Cont. Ops) | $3.47 | $8.44 | $8.56 | $6.47 | $5.05 | |
| Diluted EPS (Cont. Ops) | $3.44 | $8.32 | $8.44 | $6.42 | $5.01 | |
| Weighted Average Basic Share | $139M | $135M | $131M | $132M | $133M | |
| Weighted Average Diluted Share | $140M | $137M | $133M | $133M | $134M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $803M | $1.5B | $1.7B | $2.8B | $2.6B | |
| Revenue (Reported) | $3B | $2.9B | $3.6B | $5.1B | $4.8B | |
| Operating Income (Reported) | $638M | $1.5B | $1.5B | $1.2B | $909M | |
| Operating Income (Adjusted) | $803M | $1.5B | $1.7B | $2.8B | $2.6B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $751M | $993M | $1.3B | $1.2B | $1.2B | |
| Revenue Growth (YoY) | 1.08% | 32.22% | 35.55% | -9.88% | -3.63% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $20M | -- | $17M | $7M | -- | |
| Operating Expenses | -$347M | -$455M | -$327M | -$235M | -$227M | |
| Operating Income | $347M | $455M | $327M | $235M | $227M | |
| Net Interest Expenses | $9M | $27M | $231M | $118M | $91M | |
| EBT. Incl. Unusual Items | $332M | $455M | $327M | $235M | $227M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $70M | $104M | $76M | $51M | $51M | |
| Net Income to Company | $262M | $351M | $251M | $184M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $261M | $349M | $250M | $183M | $175M | |
| Basic EPS (Cont. Ops) | $1.92 | $2.62 | $1.85 | $1.33 | $1.37 | |
| Diluted EPS (Cont. Ops) | $1.90 | $2.60 | $1.84 | $1.32 | $1.35 | |
| Weighted Average Basic Share | $133M | $131M | $132M | $133M | $128M | |
| Weighted Average Diluted Share | $134M | $132M | $133M | $134M | $130M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $346M | $498M | $829M | $683M | $599M | |
| Revenue (Reported) | $751M | $993M | $1.3B | $1.2B | $1.2B | |
| Operating Income (Reported) | $347M | $455M | $327M | $235M | $227M | |
| Operating Income (Adjusted) | $346M | $498M | $829M | $683M | $599M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | $3.3B | $5B | $5B | $4.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $108M | -$90M | $40M | -$75M | -- | |
| Operating Expenses | -$1.5B | -$1.3B | -$1.5B | -$748M | -$913M | |
| Operating Income | $1.5B | $1.3B | $1.5B | $748M | $913M | |
| Net Interest Expenses | $37M | $56M | $660M | $568M | $390M | |
| EBT. Incl. Unusual Items | $1.5B | $1.3B | $1.5B | $723M | $913M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $326M | $290M | $340M | $162M | $196M | |
| Net Income to Company | $1.2B | $1B | $1.2B | $561M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.2B | $1B | $1.2B | $558M | $713M | |
| Basic EPS (Cont. Ops) | $8.27 | $7.65 | $8.89 | $4.03 | $5.29 | |
| Diluted EPS (Cont. Ops) | $8.20 | $7.56 | $8.84 | $4.00 | $5.23 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.6B | $1.4B | $2.9B | $2.5B | $2.4B | |
| Revenue (Reported) | $3B | $3.3B | $5B | $5B | $4.6B | |
| Operating Income (Reported) | $1.5B | $1.3B | $1.5B | $748M | $913M | |
| Operating Income (Adjusted) | $1.6B | $1.4B | $2.9B | $2.5B | $2.4B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.2B | $2.5B | $3.9B | $3.7B | $3.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $72M | -- | $32M | -$1M | $12M | |
| Operating Expenses | -$1.2B | -$1B | -$1.1B | -$696M | -$696M | |
| Operating Income | $1.2B | $1B | $1.1B | $696M | $696M | |
| Net Interest Expenses | $27M | $48M | $606M | $405M | $284M | |
| EBT. Incl. Unusual Items | $1.2B | $1B | $1.1B | $671M | $696M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $261M | $229M | $244M | $143M | $149M | |
| Net Income to Company | $940M | $801M | $848M | $528M | $371M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $936M | $797M | $844M | $525M | $544M | |
| Basic EPS (Cont. Ops) | $6.73 | $5.95 | $6.28 | $3.83 | $4.04 | |
| Diluted EPS (Cont. Ops) | $6.66 | $5.90 | $6.26 | $3.80 | $4.00 | |
| Weighted Average Basic Share | $409M | $393M | $395M | $398M | $391M | |
| Weighted Average Diluted Share | $413M | $397M | $397M | $401M | $395M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.2B | $1.1B | $2.3B | $2B | $1.8B | |
| Revenue (Reported) | $2.2B | $2.5B | $3.9B | $3.7B | $3.5B | |
| Operating Income (Reported) | $1.2B | $1B | $1.1B | $696M | $696M | |
| Operating Income (Adjusted) | $1.2B | $1.1B | $2.3B | $2B | $1.8B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1B | $1.2B | $1.8B | $1.4B | $850M | |
| Short Term Investments | $15.2B | $17.2B | $19.2B | $17.3B | $7.4B | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $16.1B | $23B | $6.8B | $10.3B | $7.5B | |
| Property Plant And Equipment | $765M | $771M | $738M | $762M | $765M | |
| Long-Term Investments | $15.6B | $22.4B | $5.3B | $9.5B | $6.5B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $88.1B | $94.6B | $85.4B | $85.8B | $79.3B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | $3.2B | $3.6B | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $39.5B | $45.9B | $43.3B | $31.5B | $30.3B | |
| Long-Term Debt | $6.1B | $3.1B | $3.4B | $6.5B | $5.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $80.1B | $86.7B | $80.2B | $79.4B | $72.8B | |
| Common Stock | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $7.7B | $7.5B | $4.8B | $6B | $6.1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $8.1B | $7.9B | $5.2B | $6.4B | $6.5B | |
| Total Liabilities and Equity | $88.1B | $94.6B | $85.4B | $85.8B | $79.3B | |
| Cash and Short Terms | $31B | $39.9B | $25.5B | $26.8B | $14.2B | |
| Total Debt | $6.1B | $3.1B | $3.4B | $6.5B | $7B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.1B | $1.7B | $1.2B | $870M | $986M | |
| Short Term Investments | $17B | $1.3B | $1B | $1.3B | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $23.9B | $6.4B | $8.9B | $7.1B | $5.7B | |
| Property Plant And Equipment | $447M | $412M | $410M | $476M | $432M | |
| Long-Term Investments | $23.7B | $5B | $8.8B | $6.2B | $4.6B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $94.5B | $84.1B | $85.7B | $79.7B | $77.4B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | $508M | $4.8B | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $44.1B | $42.8B | $34.8B | $23.9B | $22.6B | |
| Long-Term Debt | $2.8B | $3B | $6B | $6.8B | $5.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $86.7B | $79.1B | $80.7B | $72.3B | $69.9B | |
| Common Stock | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $7.8B | $5.1B | $5B | $7.4B | $7.4B | |
| Total Liabilities and Equity | $94.5B | $84.1B | $85.7B | $79.7B | $77.4B | |
| Cash and Short Terms | $40.6B | $7.2B | $9.2B | $7.7B | -- | |
| Total Debt | $2.8B | $3B | $6B | $6.8B | $5.4B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $497M | $1.2B | $1.2B | $881M | $698M | |
| Depreciation & Amoritzation | $108M | $99M | $92M | $87M | $96M | |
| Stock-Based Compensation | $24M | $41M | $60M | $52M | $54M | |
| Change in Accounts Receivable | $25M | $13M | -$152M | -$65M | $83M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $928M | $634M | $638M | $1.3B | $601M | |
| Capital Expenditures | $79M | $70M | $82M | $153M | $153M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$4.6B | $1.7B | -$10B | $3.5B | $3.3B | |
| Dividends Paid (Ex Special Dividend) | $383M | $392M | $376M | $394M | $400M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $500M | $4B | $1B | |
| Long-Term Debt Repaid | -$1.7B | -$2.8B | -- | -$850M | -$500M | |
| Repurchase of Common Stock | $199M | $729M | $43M | $17M | $114M | |
| Other Financing Activities | -$1M | $4M | -$9M | -$19M | -$14M | |
| Cash From Financing | $13.6B | $4.6B | -$7.1B | -$1.5B | -$6.6B | |
| Beginning Cash (CF) | $5.8B | $15.8B | $22.7B | $6.3B | $9.5B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $9.9B | $6.9B | -$16.4B | $3.2B | -$2.7B | |
| Ending Cash (CF) | $15.8B | $22.7B | $6.3B | $9.5B | $6.8B | |
| Levered Free Cash Flow | $849M | $564M | $556M | $1.1B | $448M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $262M | $351M | $251M | $184M | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $7M | $9M | $9M | $9M | $1M | |
| Change in Accounts Receivable | $16M | -$53M | $4M | $40M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $875M | $393M | -$178M | $1B | -$270M | |
| Capital Expenditures | $15M | $17M | $39M | $34M | $32M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $1.5B | -$289M | $2.9B | $1.8B | $655M | |
| Dividends Paid (Ex Special Dividend) | $97M | $94M | $98M | $99M | $97M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $500M | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$850M | -$500M | -- | |
| Repurchase of Common Stock | $220M | $3M | -- | -- | $151M | |
| Other Financing Activities | -$1M | $1M | -$2M | $1M | -- | |
| Cash From Financing | $5.4B | -$1.7B | -$4.9B | -$1.3B | -$634M | |
| Beginning Cash (CF) | $16.5B | $7.5B | $10.2B | $4.8B | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $7.1B | -$1.6B | -$2.1B | $1.6B | -$249M | |
| Ending Cash (CF) | $23.6B | $6B | $8.1B | $6.4B | -- | |
| Levered Free Cash Flow | $860M | $376M | -$217M | $1B | -$302M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.2B | $1B | $1.2B | $561M | -- | |
| Depreciation & Amoritzation | $102M | $94M | $85M | $93M | -- | |
| Stock-Based Compensation | $42M | $53M | $56M | $53M | $45M | |
| Change in Accounts Receivable | $10M | -$99M | -$127M | $60M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1B | -$203M | $726M | $2.1B | $125M | |
| Capital Expenditures | $78M | $78M | $117M | $178M | $101M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $3.2B | -$10B | $355M | $4.7B | $773M | |
| Dividends Paid (Ex Special Dividend) | $399M | $377M | $384M | $398M | $398M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $500M | $4B | $1B | -- | |
| Long-Term Debt Repaid | -$2.8B | -- | -- | -$500M | -- | |
| Repurchase of Common Stock | $679M | $93M | $16M | $14M | $403M | |
| Other Financing Activities | -- | $2M | -- | -$16M | -- | |
| Cash From Financing | $8.8B | -$8.1B | $1.1B | -$8.5B | -$2.3B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $12.4B | -$17.6B | $2.1B | -$1.7B | -$1.4B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $950M | -$281M | $609M | $1.9B | $24M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $940M | $801M | $848M | $528M | $371M | |
| Depreciation & Amoritzation | $25M | $23M | $20M | $22M | $50M | |
| Stock-Based Compensation | $36M | $48M | $44M | $45M | $36M | |
| Change in Accounts Receivable | $17M | -$95M | -$70M | $55M | $13M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $878M | $41M | $129M | $955M | $479M | |
| Capital Expenditures | $50M | $58M | $93M | $118M | $66M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $3.2B | -$8.5B | $1.8B | $3B | $520M | |
| Dividends Paid (Ex Special Dividend) | $298M | $283M | $291M | $295M | $293M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $500M | $4B | $1B | -- | |
| Long-Term Debt Repaid | -$2.8B | -- | -$850M | -$500M | -$1B | |
| Repurchase of Common Stock | $679M | $43M | $16M | $13M | $302M | |
| Other Financing Activities | $2M | -- | -$2M | $1M | -$1M | |
| Cash From Financing | $4.4B | -$8.2B | -$78M | -$7.1B | -$2.8B | |
| Beginning Cash (CF) | $47.1B | $43.8B | $27.2B | $19.4B | $12.6B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $7.8B | -$16.7B | $1.8B | -$3.1B | -$1.8B | |
| Ending Cash (CF) | $55B | $27.1B | $29.1B | $16.3B | $11.1B | |
| Levered Free Cash Flow | $828M | -$17M | $36M | $837M | $413M | |
Get CMA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CMA
Sector
P/E ratio
16.64x
12.15x
PEG ratio
0.54x
0.31x
P/B ratio
1.58x
1.10x
Price / LTM sales
2.48x
1.82x
Growth Metrics
CMA
Sector
Revenue growth
-3.63%
5.54%
Earnings growth
1.92%
14.85%
Revenue (5-year growth)
5.16%
8.84%
Earnings forecast
$1.26
$0.64
Profitability
CMA
Sector
Profitability FY 2024
--
--
Return on invested capital
5.08%
5.01%
Return on assets
0.91%
1.01%
Return on equity
10.11%
9.67%
Earnings Date
Last Earnings Date
Oct
17
Next Earnings Date
Jan
23
Estimated Next Earnings Date
Jan
16
Balance Sheet
CMA
Sector
Total cash
$12.9B
$430.8M
Short term investments
$7.4B
$211.1M
Total assets
$79.3B
$3.1B
Long term debt
$5.4B
$79M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 2
Corcept Therapeutics, Inc. [CORT] is up 5.92% over the past day.
Buy
75
AXSM alert for Jan 2
Axsome Therapeutics, Inc. [AXSM] is down 2.76% over the past day.
Sell
50
NUTX alert for Jan 2
Nutex Health, Inc. [NUTX] is down 8.14% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
